Baxter International (BAX) Competitors $31.93 -0.70 (-2.15%) (As of 12:52 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BAX vs. BDX, EW, RMD, IDXX, DXCM, STE, PODD, HOLX, GMED, and TFXShould you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Globus Medical (GMED), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Baxter International vs. Becton, Dickinson and Company Edwards Lifesciences ResMed IDEXX Laboratories DexCom STERIS Insulet Hologic Globus Medical Teleflex Becton, Dickinson and Company (NYSE:BDX) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation. Which has more risk and volatility, BDX or BAX? Becton, Dickinson and Company has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Do insiders and institutionals have more ownership in BDX or BAX? 87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 0.3% of Becton, Dickinson and Company shares are held by insiders. Comparatively, 0.2% of Baxter International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable valuation & earnings, BDX or BAX? Baxter International has lower revenue, but higher earnings than Becton, Dickinson and Company. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBecton, Dickinson and Company$20.18B3.31$1.73B$5.9438.93Baxter International$14.81B1.12$2.66B$0.20163.21 Does the MarketBeat Community prefer BDX or BAX? Baxter International received 136 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 65.68% of users gave Baxter International an outperform vote while only 62.38% of users gave Becton, Dickinson and Company an outperform vote. CompanyUnderperformOutperformBecton, Dickinson and CompanyOutperform Votes59762.38% Underperform Votes36037.62% Baxter InternationalOutperform Votes73365.68% Underperform Votes38334.32% Do analysts rate BDX or BAX? Becton, Dickinson and Company currently has a consensus target price of $283.00, indicating a potential upside of 22.37%. Baxter International has a consensus target price of $40.91, indicating a potential upside of 25.33%. Given Baxter International's higher possible upside, analysts clearly believe Baxter International is more favorable than Becton, Dickinson and Company.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Becton, Dickinson and Company 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Baxter International 1 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.18 Does the media favor BDX or BAX? In the previous week, Becton, Dickinson and Company had 13 more articles in the media than Baxter International. MarketBeat recorded 45 mentions for Becton, Dickinson and Company and 32 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 0.83 beat Baxter International's score of 0.24 indicating that Becton, Dickinson and Company is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Becton, Dickinson and Company 21 Very Positive mention(s) 2 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 4 Very Positive mention(s) 3 Positive mention(s) 14 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Is BDX or BAX more profitable? Becton, Dickinson and Company has a net margin of 8.55% compared to Baxter International's net margin of 0.77%. Baxter International's return on equity of 18.19% beat Becton, Dickinson and Company's return on equity.Company Net Margins Return on Equity Return on Assets Becton, Dickinson and Company8.55% 14.89% 6.98% Baxter International 0.77%18.19%5.39% Is BDX or BAX a better dividend stock? Becton, Dickinson and Company pays an annual dividend of $3.80 per share and has a dividend yield of 1.6%. Baxter International pays an annual dividend of $1.16 per share and has a dividend yield of 3.6%. Becton, Dickinson and Company pays out 64.0% of its earnings in the form of a dividend. Baxter International pays out 580.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Becton, Dickinson and Company has increased its dividend for 53 consecutive years. SummaryBecton, Dickinson and Company beats Baxter International on 12 of the 21 factors compared between the two stocks. Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Get Baxter International News Delivered to You Automatically Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BAX vs. The Competition Export to ExcelMetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$16.65B$4.62B$5.22B$19.95BDividend Yield3.43%39.52%4.98%3.50%P/E Ratio163.2119.72118.8643.25Price / Sales1.1262.831,303.2618.17Price / Cash6.4552.4438.8921.68Price / Book1.965.616.394.66Net Income$2.66B$13.58M$118.47M$982.08M7 Day Performance-9.43%-0.19%-0.90%-0.70%1 Month Performance-11.57%7.12%3.48%1.80%1 Year Performance-4.95%55.11%36.62%25.97% Baxter International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BAXBaxter International4.7982 of 5 stars$31.93-2.1%$40.91+28.1%-3.2%$16.29B$14.81B159.6660,000Earnings ReportDividend CutAnalyst ForecastShort Interest ↓BDXBecton, Dickinson and Company4.9465 of 5 stars$231.26-1.4%N/A-2.0%$66.84B$20.18B38.9373,000Earnings ReportDividend IncreaseShort Interest ↓Analyst RevisionEWEdwards Lifesciences4.5714 of 5 stars$65.81-1.3%N/A+3.0%$38.81B$6.00B9.5019,800Insider SellingShort Interest ↓RMDResMed4.7595 of 5 stars$247.11-0.6%N/A+64.8%$36.27B$4.81B32.739,980Insider SellingAnalyst RevisionPositive NewsIDXXIDEXX Laboratories4.8889 of 5 stars$426.11-2.6%N/A-0.6%$34.89B$3.84B41.0911,000Short Interest ↓Positive NewsDXCMDexCom4.9837 of 5 stars$74.34+5.7%N/A-26.3%$29.04B$3.95B44.529,600Short Interest ↑Positive NewsSTESTERIS4.9614 of 5 stars$222.73+0.4%N/A+9.9%$21.96B$5.33B50.8518,179Short Interest ↓PODDInsulet4.4324 of 5 stars$275.10-0.2%N/A+64.4%$19.29B$1.98B47.113,000Analyst ForecastAnalyst RevisionHOLXHologic4.8889 of 5 stars$79.76+0.5%N/A+10.9%$18.53B$4.03B23.956,990Analyst UpgradeShort Interest ↓Analyst RevisionGMEDGlobus Medical4.7102 of 5 stars$83.48+1.8%N/A+88.5%$11.30B$1.57B124.605,000Analyst ForecastTFXTeleflex4.9391 of 5 stars$195.58-1.2%N/A-4.8%$9.08B$3.03B38.8814,500Analyst UpgradeAnalyst Revision Related Companies and Tools Related Companies BDX Competitors EW Competitors RMD Competitors IDXX Competitors DXCM Competitors STE Competitors PODD Competitors HOLX Competitors GMED Competitors TFX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BAX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.